HealthNotableConfirmed
5.9
FDA approves Roche and Eli Lilly Alzheimer's blood diagnostic test
Valor Econômico·US·3 days ago
The regenerative medicine sector is transitioning from experimental laboratory research to clinical application, focusing on cell, tissue, and biomaterial therapies. Market analysis indicates significant growth, with valuations expected to rise from $48.17 billion in 2025 to $58.40 billion in 2026, reflecting increased investment and therapeutic development.